Research-focused oncologist/hematologist joins HOA

Board-certified oncologist and hematologist Ajeet Gajra has recently joined Hematology-Oncology Associates of CNY (HOA).

In addition to extensive cancer-research experience, Gajra also is board-certified in hospice and palliative care
His cancer research includes serving as a principal investigator for more than 40 clinical trials, including pharmaceutical sponsored, US cooperative group and investigator-initiated studies. In addition, he served as medical director for oncology at ICON research, a top 3 global clinical research organization.

There he led design, oversight, clinical development and regulatory interactions for phase I-IV trials in oncology and hematology, including immuno-oncology, and CAR-T cell therapy.

“Adding Dr. Gajra’s expertise to our team increases our ability to expand our therapeutic research efforts for patients in Central New York,” said Maryann Roefaro, HOA’s chief executive officer.

“By providing convenient, world-class care in our community, patients can receive treatments close to their loved ones without added costs of time and travel.”

Having most recently served as the chief medical officer at Cardinal Health, Gajra was previously associate director of the Upstate Cancer Center, where he also served as medical director.

In addition to providing clinical care to patients with all types of cancers and blood disorders, Gajra has served on the medical faculty at SUNY Upstate Medical University as a professor of medicine and program director for the hematology/oncology fellowship.

Gajra received his medical degree in internal medicine from Delhi University, India, and completed his residency at SUNY Upstate Medical University, where he also completed his fellowship in medical oncology and hematology.

A member of Alpha Omega Alpha honor society, Gajra has received numerous patient-care quality awards, including the Anita Award from Hospice of CNY. He also was awarded fellowship by American College of Physicians in 2011, and served on the lung cancer guidelines committee of the American Society of Clinical Oncology (ASCO).

Gajra has published over 110 peer-reviewed manuscripts in journals, including Journal of Clinical Oncology, Cancer, Lancet Oncology, New England Journal of Medicine and Blood. He also has co-authored or presented more than 160 abstracts at notable scientific meetings, including ASCO, the American Society of Hematology (ASH) and the American Association for Cancer Research (AACR).